23andMe Holding Co.
NASDAQ:ME

Watchlist Manager
23andMe Holding Co. Logo
23andMe Holding Co.
NASDAQ:ME
Watchlist
Price: 0.6063 USD -21.26% Market Closed
Market Cap: 88.5m USD

Wall Street
Price Targets

ME Price Targets Summary
23andMe Holding Co.

Wall Street analysts forecast ME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ME is 2.1216 USD with a low forecast of 2.1008 USD and a high forecast of 2.184 USD.

Lowest
Price Target
2.1008 USD
246% Upside
Average
Price Target
2.1216 USD
250% Upside
Highest
Price Target
2.184 USD
260% Upside
23andMe Holding Co. Competitors:
Price Targets
1951
Jinxin Fertility Group Ltd
13% Upside
WGS
GeneDx Holdings Corp
34% Upside
ADUS
Addus Homecare Corp
27% Upside
IDX
Integral Diagnostics Ltd
16% Upside
OPCH
Option Care Health Inc
31% Upside
002044
Meinian Onehealth Healthcare Holdings Co Ltd
35% Upside
TALK
Talkspace Inc
95% Upside
RDNT
RadNet Inc
27% Upside

Revenue
Forecast

Revenue Estimate
23andMe Holding Co.

For the last 4 years the compound annual growth rate for 23andMe Holding Co.'s revenue is -8%. The projected CAGR for the next 2 years is 20%.

-8%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
23andMe Holding Co.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
23andMe Holding Co.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ME's stock price target?
Price Target
2.1216 USD

According to Wall Street analysts, the average 1-year price target for ME is 2.1216 USD with a low forecast of 2.1008 USD and a high forecast of 2.184 USD.

What is 23andMe Holding Co.'s Revenue forecast?
Projected CAGR
20%

For the last 4 years the compound annual growth rate for 23andMe Holding Co.'s revenue is -8%. The projected CAGR for the next 2 years is 20%.

Back to Top